J. P. Costantino

1.7k total citations · 1 hit paper
39 papers, 1.1k citations indexed

About

J. P. Costantino is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. P. Costantino has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cancer Research, 22 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. P. Costantino's work include Breast Cancer Treatment Studies (28 papers), Advanced Breast Cancer Therapies (13 papers) and Cancer Treatment and Pharmacology (10 papers). J. P. Costantino is often cited by papers focused on Breast Cancer Treatment Studies (28 papers), Advanced Breast Cancer Therapies (13 papers) and Cancer Treatment and Pharmacology (10 papers). J. P. Costantino collaborates with scholars based in United States, Germany and Canada. J. P. Costantino's co-authors include Norman Wolmark, EP Mamounas, Sandra M. Swain, Thomas B. Julian, Stewart Anderson, Irene Wapnir, Bernard Fisher, James J. Dignam, Stephanie R. Land and Richard G. Margolese and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

J. P. Costantino

38 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

2011 517 citations Irene Wapnir, James J. Dignam et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. P. Costantino United States	14	801	541	398	194	192	39	1.1k
Boon Chua Australia	21	934 1.2×	486 0.9×	555 1.4×	357 1.8×	172 0.9×	57	1.2k
Jane Pettinga United States	16	911 1.1×	363 0.7×	532 1.3×	352 1.8×	139 0.7×	31	1.1k
Dan Lundstedt Sweden	14	739 0.9×	416 0.8×	274 0.7×	285 1.5×	274 1.4×	30	1.1k
Lars Stenbygaard Denmark	12	516 0.6×	657 1.2×	135 0.3×	121 0.6×	142 0.7×	29	1.1k
Gunilla Svane Sweden	25	729 0.9×	571 1.1×	611 1.5×	147 0.8×	414 2.2×	58	1.6k
S. Giard France	20	982 1.2×	469 0.9×	663 1.7×	428 2.2×	145 0.8×	66	1.2k
R Collins Hong Kong	3	497 0.6×	256 0.5×	220 0.6×	169 0.9×	150 0.8×	3	682
F. Laki France	14	475 0.6×	216 0.4×	278 0.7×	182 0.9×	90 0.5×	40	658
Kristine E. Kokeny United States	14	409 0.5×	304 0.6×	188 0.5×	260 1.3×	102 0.5×	40	812
M. Del Vecchio Italy	6	545 0.7×	271 0.5×	340 0.9×	237 1.2×	59 0.3×	12	713

Countries citing papers authored by J. P. Costantino

Since Specialization

Citations

This map shows the geographic impact of J. P. Costantino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. P. Costantino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. P. Costantino more than expected).

Fields of papers citing papers by J. P. Costantino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. P. Costantino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. P. Costantino. The network helps show where J. P. Costantino may publish in the future.

Co-authorship network of co-authors of J. P. Costantino

This figure shows the co-authorship network connecting the top 25 collaborators of J. P. Costantino. A scholar is included among the top collaborators of J. P. Costantino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. P. Costantino. J. P. Costantino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loibl, Sibylle, Christian Jackisch, Priya Rastogi, et al.. (2019). GeparDouze/NSABP B-59: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy with atezolizumab or placebo in patients with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo. Annals of Oncology. 30. iii38–iii38. 9 indexed citations

Pogue-Geile, KL, Yun Wang, Ashok Srinivasan, et al.. (2019). Abstract P3-10-04: The fully validated NSABP/NRG 8-gene signature which predicted the degree of benefit in the adjuvant setting (B-31 and NCCTG N9831) associates with pCR in the neoadjuvant setting in NSABP clinical trial FB-7. Cancer Research. 79(4_Supplement). P3–10. 1 indexed citations

Geyer, CE, Sibylle Loibl, Priya Rastogi, et al.. (2019). Abstract OT3-05-01: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy (NAC) with atezolizumab or placebo in patients (pts) with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo: NSABP B-59/GBG 96-GeparDouze. Cancer Research. 79(4_Supplement). OT3–5. 1 indexed citations

Ganz, PA, TB Julian, J. P. Costantino, et al.. (2016). Abstract S6-04: Patient-reported outcome (PRO) results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) vs tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy. Cancer Research. 76(4_Supplement). S6–4. 1 indexed citations

Mamounas, EP, Hanna Bandos, TB Julian, et al.. (2016). Abstract OT2-02-02: NRG Oncology/NSABP B-51/RTOG 1304: A phase III clinical trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes who are ypN0 after neoadjuvant chemotherapy (NC). Cancer Research. 76(4_Supplement). OT2–2. 2 indexed citations

Swain, SM, J. P. Costantino, Priya Rastogi, et al.. (2013). Abstract PD2-1: Body mass index at diagnosis and breast cancer survival prognosis among clinical trial populations: Results from NSABP B-30, B-31, B-34, and B-38. Cancer Research. 73(24_Supplement). PD2–1. 1 indexed citations

Holmes, Eileen, M. Spielmann, EA Perez, et al.. (2013). Abstract S6-03: The prognosis of small HER2+ breast cancers: A meta-analysis of the randomized trastuzumab trials. Cancer Research. 73(24_Supplement). S6–3. 1 indexed citations

Wickerham, D. L., et al.. (2011). Cigarette smoking, fitness, and alcohol use as predictors of cancer outcomes among women in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial (BCPT).. Journal of Clinical Oncology. 29(15_suppl). 1505–1505. 4 indexed citations

Wapnir, Irene, James J. Dignam, Bernard Fisher, et al.. (2011). Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS. JNCI Journal of the National Cancer Institute. 103(6). 478–488. 517 indexed citations breakdown →

10.

Lembersky, BC, Louis Fehrenbacher, CI Falkson, et al.. (2011). S2-3: NSABP Protocol B-34: A Clinical Trial Comparing Adjuvant Clodronate vs. Placebo in Early Stage Breast Cancer Patients Receiving Systemic Chemotherapy and/or Tamoxifen or No Therapy – Final Analysis.. Cancer Research. 71(24_Supplement). S2–3. 14 indexed citations

11.

Julian, Thomas B., J. P. Costantino, Frank A. Vicini, et al.. (2011). Early toxicity results with 3D conformal external beam therapy (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial.. Journal of Clinical Oncology. 29(15_suppl). 1011–1011. 68 indexed citations

12.

Eng‐Wong, Jennifer, J. P. Costantino, & Sandra M. Swain. (2010). The Impact of Systemic Therapy Following Ductal Carcinoma In Situ. JNCI Monographs. 2010(41). 200–203. 13 indexed citations

13.

Julian, Thomas B., Stuart Anderson, Peiyong Zheng, et al.. (2009). Predictive Factors for Positive Non-Sentinel Nodes Following a Positive Sentinel Node Biopsy: NSABP B-32.. Cancer Research. 69(24_Supplement). 301–301.

14.

Shen, Yu, J. P. Costantino, & Jing Qin. (2008). Tamoxifen Chemoprevention Treatment and Time to First Diagnosis of Estrogen Receptor-Negative Breast Cancer. JNCI Journal of the National Cancer Institute. 100(20). 1448–1453. 14 indexed citations

15.

Cronin, Walter M., et al.. (2008). Factors associated with participant adherence in the NSABP Study of Tamoxifen and Raloxifene (STAR). Journal of Clinical Oncology. 26(15_suppl). 6518–6518. 3 indexed citations

16.

Julian, Thomas B., et al.. (2008). Is boost therapy necessary in the treatment of DCIS?. Journal of Clinical Oncology. 26(15_suppl). 537–537. 17 indexed citations

17.

Dignam, James J., Vanja Dukić, Stewart Anderson, et al.. (2007). Time-dependent patterns of recurrence after early stage breast cancer: Preliminary observations and methodological issues. Journal of Clinical Oncology. 25(18_suppl). 536–536. 5 indexed citations

18.

Paik, Soonmyung, Jong‐Hyeon Jeong, Charles E. Geyer, et al.. (2007). Benefit from adjuvant trastuzumab may not be confined to patients with IHC 3+ and/or FISH-positive tumors: Central testing results from NSABP B-31. Journal of Clinical Oncology. 25(18_suppl). 511–511. 56 indexed citations

19.

Holmberg, Christine, Lucile L. Adams‐Campbell, J. P. Costantino, John W. Pearson, & Worta McCaskill‐Stevens. (2005). Determinants of participation in the Study of Tamoxifen and Raloxifene (STAR): Experience of a minority-based community oncology program. Journal of Clinical Oncology. 23(16_suppl). 1011–1011. 1 indexed citations

20.

Costantino, J. P., et al.. (1990). Inductance plethysmography measurement of CPAP-induced changes in end-expiratory lung volume. Journal of Applied Physiology. 68(4). 1732–1738. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact